Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Programmed Death Ligand-1 Expression in Gliomas: A Study of Histopathological and Molecular Associations.

Neurology India - 1 Jan 2000

Shukla Saumya, Husain Nuzhat, Kaif Mohammed, Awale Rupali Bhalchandra, Mishra Sridhar, Malhotra Kiran Preet

Abstract excerpt

BACKGROUND: Gliomas are aggressive tumors with limited treatment options. Immunotherapy targets are under evaluation as new therapeutic targets in gliomas. AIMS AND OBJECTIVES: The aims of the study were to analyze expression of PDL1 in adult diffuse gliomas in World Health Organization grade II, III, and IV and to corelate its expression with demographic features, IDH-1, ATRX, and p-53 mutation status. MATERIALS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Mutation

Source

Identifiers

PMID: 34507430
DOI: 10.4103/0028-3886.325352

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Programmed Death Ligand-1 Expression in Gliomas: A Study of Histopathological and Molecular Associations.PMID 34507430Read ↗

PD-1 related transcriptome profile and clinical outcome in diffuse gliomasSemantic proximity Read ↗

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade gliomaSemantic proximity Read ↗

Correlation of immune phenotype with IDH mutation in diffuse glioma.Semantic proximity Read ↗

Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomasSemantic proximity Read ↗

Histomolecular classification of adult diffuse gliomas: The diagnostic value of immunohistochemical markersSemantic proximity Read ↗

Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain gliomaSemantic proximity Read ↗

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme.Semantic proximity Read ↗

P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.Semantic proximity Read ↗

PD 1 and PDL 1 expression in primary central nervous system diffuse large B‐cell lymphoma are frequent and expression of PD 1 predicts poor survivalSemantic proximity Read ↗

Role of RIPK1 in Diffuse Gliomas pathologySemantic proximity Read ↗

The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.Semantic proximity Read ↗

PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.